(Q42459947)

English

Methamphetamine self-administration results in persistent dopaminergic pathology: implications for Parkinson's disease risk and reward-seeking

scientific article published on 30 May 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Methamphetamine self-administration results in persistent dopaminergic pathology: implications for Parkinson's disease risk and reward-seeking (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

0 references

1 reference

based on heuristic

inferred from title

Parkinson's disease

1 reference

based on heuristic

inferred from title

author name string

Sharanya M Kousik

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Paul M Carvey

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

T Celeste Napier

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

language of work or name

0 references

publication date

30 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

European Journal of Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

2707-2714

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Effect of schedule of reinforcement on cue-elicited reinstatement of cocaine-seeking behavior

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Dopamine D(1) receptor deletion strongly reduces neurotoxic effects of methamphetamine

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Time-course of methamphetamine-induced neurotoxicity in rat caudate-putamen after single-dose treatment

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

In vivo evidence for long-term CNS toxicity, associated with chronic binge use of methamphetamine

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Parkinson's disease: mechanisms and models

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerability.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Mirtazapine alters cue-associated methamphetamine seeking in rats

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Methamphetamine toxicity and messengers of death

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Medication improves balance and complex gait performance in Parkinson disease

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Immunochemical analysis of dopamine transporter protein in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Transient elevation of adult hippocampal neurogenesis after dopamine depletion

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Differential regulation of tyrosine hydroxylase by continuous and intermittent hypoxia

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Role of the serotonin uptake carrier in the neurochemical response to methamphetamine: effects of citalopram and chlorimipramine.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Treatment of mice with methamphetamine produces cell loss in the substantia nigra.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Interactions between methamphetamine and environmental stress: role of oxidative stress, glutamate and mitochondrial dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Neurotoxic effects of methamphetamine.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Amphetamine toxicities: classical and emerging mechanisms.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Mapping of transmitter-specific connections: simultaneous demonstration of anterograde degeneration and changes in the immunostaining pattern induced by lesions.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Compartments in rat dorsal and ventral striatum revealed following injection of 6-hydroxydopamine into the ventral mesencephalon.

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Aetiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment

1 reference

https://api.crossref.org/works/10.1111%2FEJN.12628

21 January 2018

Identifiers

10.1111/EJN.12628

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42459947&oldid=1958166597"